CSC-Mediated Immunosuppression

Cancer stem cells (CSCs) are adept at creating an immunosuppressive microenvironment, enabling them to evade immune attack. This track focuses on how CSCs manipulate immune cells, such as T-cells, macrophages, and dendritic cells, to suppress anti-tumor immune responses. Researchers explore how CSCs produce immunosuppressive factors like IL-10, TGF-β, and PD-L1, which inhibit immune cell activation and function. By targeting these immunosuppressive mechanisms, new therapeutic strategies could be developed to enhance the immune system’s ability to recognize and eliminate CSCs. This research highlights the importance of combining immunotherapy with CSC-targeted approaches to improve cancer treatment outcomes.

    Related Conference of CSC-Mediated Immunosuppression

    March 10-11, 2025

    3rd World Congress on Oral Cancer

    Paris, France
    March 24-25, 2025

    25th World Congress on Cancer and Diagnostics

    London, UK
    March 24-25, 2025

    10th World Conference on Breast and Cervical Cancer

    Paris, France
    April 07-08, 2025

    15th World Congress on Breast Cancer

    Vancouver, Canada
    June 16-17, 2025

    26th World Congress on Cancer Summit

    Amsterdam, Netherlands
    July 14-15, 2025

    5th World Congress on Breast Cancer

    Berlin, Germany
    October 20-21, 2025

    21st International Conference on Cancer Research

    Barcelona, Spain

    CSC-Mediated Immunosuppression Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in